obesity

TRIUMPH Trial Retatrutide Phase 3 Obesity Study

Discover the groundbreaking TRIUMPH trial for retatrutide and its pivotal role in the phase 3 obesity journey towards FDA approval, revealing astonishing weight loss results and new hope for effective obesity treatments.

AdminApr 1811 min

Clinical Trials & Research

Retatrutide NEJM 2023 Phase 2 Obesity Results

The retatrutide NEJM 2023 phase 2 obesity trial reveals groundbreaking weight loss results, with participants losing an average of 24.2% of their body weight — but what does the data truly convey about its potential in obesity treatment?

AdminApr 1813 min

Obesity & Metabolic Health

Evolution of Obesity Pharmacotherapy with New Drugs

Explore the fascinating evolution of obesity pharmacotherapy, from early GLP-1 therapies to the groundbreaking triple agonists like tirzepatide and retatrutide, showcasing how peptide engineering has revolutionized treatment options.

AdminApr 1810 min